Purchase Order 75D30121P11283
Award Date 8/13/21
Potential Completion Date 8/12/22
Potential Value $200K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Oakland, CA 94612, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, is valued at $1,772,230.00. It was awarded by the Centers for Disease Control and Prevention (CDC) on April 9, 2020 and has an ultimate completion date of August 6, 2023. The contract is for "INNOVATIVE METHODS TO INFORM ESTIMATES OF VACCINE EFFECTIVENESS USING INFORMATION" and is a firm fixed-price definitive contract. No set-aside was used....
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a division of the non-profit Kaiser Permanente healthcare system, to establish a virtual network to investigate the effectiveness of COVID-19 and influenza vaccines. The contract is a definitive, firm fixed-price award with a ceiling value of $2,587,498.00 and a completion date of September 6, 2027. This contract is not set aside and leverages Kaiser Permanente's...
- This is a federal contract award to Kaiser Foundation Hospitals, the Kaiser Foundation Research Institute Division doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract was awarded by the Centers for Disease Control and Prevention (CDC) for $150,000.00 on a firm fixed price basis. The contract is not designated as a set-aside. The contract work is described as being for "other functions morbidity", which suggests it involves...
- This is a $646,694.92 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract is for the Vaccine Safety Datalink (VSD) project, a collaborative effort between the CDC and integrated healthcare systems to conduct post-licensure vaccine safety monitoring and evaluation. The award has no set-aside designation,...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a division of the Kaiser Foundation Research Institute, doing business as Kaiser Permanente. The contract does not have a set-aside designation. The contract, valued at $116,534, is for IMPACT OF HPV research. Kaiser Permanente, a non-profit healthcare provider and research organization, has extensive experience supporting federal public health...
- The Centers for Disease Control and Prevention (CDC) awarded a $1,133,214 firm fixed-price contract to Kaiser Foundation Hospitals for the purchase of aggregated pre-exposure prophylaxis (PrEP) prescription data from three regions covering most Kaiser insurance enrollees. The contract has an ultimate completion date of August 31, 2027. This sole-source contract was awarded without a set-aside designation. It will allow the CDC to supplement its existing surveillance and evaluation activities...
- The Centers for Disease Control and Prevention (CDC) awarded a $11,470,897.31 firm fixed price contract to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract, titled "CDC CFA EPID STUDIES", is not set aside for any special business designation. The contract supports epidemiology studies and investigations, leveraging Kaiser Permanente's access to large-scale electronic medical record data covering...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $748,171 delivery order contract to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for PEDIATRIC COVID VACCINATION services. This contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) program, a $86 million indefinite delivery vehicle that supports epidemiological and clinical research to evaluate vaccine safety. The contract has no set-aside designation, reflecting Kaiser Permanente's...
- This is a definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for a prospective observational cohort study to assess the effectiveness of SARS-CoV-2 vaccines. The $55,223,588.00 contract has an ultimate completion date of December 31, 2024 and is a cost-no-fee arrangement. The contract does not have a set-aside designation. Kaiser Permanente is collaborating with the University of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded an $11,542 firm fixed price purchase order to Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, to conduct follow up of seed participants in California. As the prime contractor, Kaiser Permanente will perform the work itself in Atlanta, Georgia under the one year contract running from September 2022 through December 2023. The Centers for...